There is just enough news here for a quick Cost Curve. I worry if I don’t put a marker down, it’ll all be swamped by the nice time I’m in
I’m paying the price for yesterday’s decision to go all-in on the Minnesota 340B report. There’s a lot to get through. Pitter patter. Tomorrow’s Curve will be a game-time decision,
I was working through the full newsletter this morning when I saw that the Minnesota 340B report dropped. So I think it’s worth a special edition today. That doesn’t mean
Plenty of catching up to do today. Thanks for spending your Friday with me. Thank goodness it’s a bye week for the Hockey East-leading Terriers. If you want to search
Confession: after a week of what feels like daily bombshells, I fear my brain is full. There’s plenty to talk about today that has gone under-recognized or under-analyzed, but there’s
I’m now over at Bluesky as @brianreid.bsky.social. I really don’t need another social account to tend to, so most of my posting will remain at LinkedIn. But the community at
Minnesota 340B Watch Update. I emailed the nice folks at the Minnesota Department of Health about where their 340B transparency report, and I quickly received a brief reply: “We hope
I keep promoting a big Minnesota state report on 340B that keeps not appearing. Per statute, something was supposed to go from the state’s Minnesota Department of Health to the
We’re going to talk about Robert Kennedy today. Here’s the tweet announcing his nomination. Here’s reaction from PhRMA and BIO. I haven’t seen anything from the American Hospital Association or
It’s still all mostly politics out there, with heat but no light when it comes to the topics that we’re focused on here. So most of the newsletter is deep